Myriad Genetics Reports Solid Q3 2024 Growth Amid Challenges
Myriad Genetics ( (MYGN) ) has released its Q3 earnings. Here is a breakdown of the information Myriad Genetics presented to its investors.
Business Wire2d
MYGN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Myriad Genetics, Inc. and Encourages Investors to Contact the Firm
NEW YORK--(BUSINESS WIRE)--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Myriad Genetics, Inc. (“Myriad” or “the Company”) ...
Zacks.com on MSN2d
Myriad Genetics (MYGN) Q3 Earnings and Revenues Surpass Estimates
Myriad Genetics (MYGN) came out with quarterly earnings of $0.06 per share, beating the Zacks Consensus Estimate of $0.02 per share. This compares to loss of $0.03 per share a year ago. These figures ...
Myriad Genetics Reports Third Quarter 2024 Financial Results; Updates 2024 Financial Guidance
HighlightsThird quarter revenue grew 11% year-over-year to $213 million, driven by Pharmacogenomics (34%) and Prenatal (10%) and progress on ...
Today5d
Jill Martin raises awareness of genetic testing for breast cancer on Football Night in America
Ahead of the Bengals-Giants game on Sunday, Oct. 13, Jill joined the program to discuss her history with breast cancer and urge viewers to consider genetic testing if they're high risk — a step ...
Case Western Reserve University20d
Genetic Counseling Training Program
Master of Science degree in Genetic Counseling Master of Science in Genetic Counseling and Master of Arts in Bioethics (dual degree program) The Master of Science degree in Genetic Counseling is ...